SCHEMBL587187

SCHEMBL587187

CC(C)CC(C(=O)[O-])C(CC(C)C)(C(=O)[O-])S(=O)(=O)O.[Na+].[Na+]

nearest known ligand 0.31

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770672 0.77 CA2 (0.36) CA2
SCHEMBL11147952 0.76
SCHEMBL19356957 0.76 CA1 (0.42) CA2
SCHEMBL8410580 0.75 TRPA1 (0.37)
SCHEMBL8903392 0.75 CYP3A4 (0.34) CA2
SCHEMBL3140302 0.75 RNPEP (0.34)
SCHEMBL2957899 0.75 CA2 (0.36) CA2
SCHEMBL587188 0.73 RNPEP (0.33)
Ammonia Solution, Strong SCHEMBL28190325 0.73 RNPEP (0.33)
SCHEMBL51225 0.73 CA2 (0.42) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4061857-B1 POLYMER DISPERSION MADE FROM (METH)ACRYLATES HAVING LONG SIDE CHAINS EVONIK OPERATIONS GMBH (DE) 2026-05-06 EP claimed
CN-111356369-B Liquid herbicidal composition 株式会社LG化学 2022-11-18 CN claimed
EP-1673417-B1 SOLID-LIQUID SEPARATION OF OIL-BASED MUDS KEMIRA OYJ (FI) 2016-02-24 EP claimed
WO-2011065855-A1 \"BIOCOMPOSTABLE POLYMER BLENDS\ CABOPOL - INDÚSTRIA DE COMPOSTOS, S.A. (PT) 2011-06-03 WO claimed
US-20100184816-A1 Method for Reducing the Phytotoxicity of Azoles on Dicotyledonous Plants by Adding Additives BAYER CROPSCIENCE AG (DE) 2010-07-22 US claimed
WO-2009000407-A1 METHOD FOR REDUCING THE PHYTOTOXICITY OF AZOLES ON DICOTYLEDONOUS PLANTS BY ADDING ADDITIVES BAYER CROPSCIENCE AG (DE) 2008-12-31 WO claimed
US-7381332-B2 Solid-liquid separation of oil-based muds KEMIRA OYJ (FI) 2008-06-03 US claimed
US-7138079-B2 Methods for making foamed elastomer gels EDIZONE, LC (US) 2006-11-21 US claimed
EP-1673417-A2 SOLID-LIQUID SEPARATION OF OIL-BASED MUDS Cytec Technology Corp. (US) 2006-06-28 EP claimed
EP-1607499-A1 Chlorine resistant elastane fibres protected against color change Dorlastan Fibers GmbH (DE) 2005-12-21 EP claimed
EP-0673984-B1 Aqueous based drilling fluid additive and composition MI LLC (US) 1999-06-09 EP claimed
US-5639715-A Aqueous based drilling fluid additive and composition M-I DRILLING FLUIDS LLC 1997-06-17 US claimed
EP-0673984-A1 Aqueous based drilling fluid additive and composition M-I DRILLING FLUIDS COMPANY (US) 1995-09-27 EP claimed
EP-0288618-B1 METHOD FOR RELEASING RNA AND DNA FROM CELLS GEN-PROBE INCORPORATED (US) 1993-07-21 EP claimed
EP-0229442-B1 ACCELERATED NUCLEIC ACID REASSOCIATION METHOD GEN-PROBE INCORPORATED (US) 1993-01-27 EP claimed
US-4985162-A SULFOSUCCINATE, NONIONIC SURFACTANT, ANTIFOAM AGENT WEN-DON CORPORATION (US) 1991-01-15 US claimed
EP-0075442-B1 PROCESS FOR PRODUCING BENZOYL PEROXIDE CRYSTALS OF A SMALL SIZE WARNER-LAMBERT COMPANY (US) 1985-07-24 EP claimed
US-4252603-A DISPERSION, AGGLOMERATION, FILTRATION, REUSE OF SURFACTANT ICI AUSTRALIA LIMITED (AU) 1981-02-24 US claimed
US-4226672-A TREATING WITH SURFACTANT, FIBERIZING, DILUTING, CLASSIFYING, AGGLOMERATING, DEWATERING ICI AUSTRALIA LIMITED (AU) 1980-10-07 US claimed
US-4190456-A DISPERSION, AGGLOMERIZATION ICI AUSTRALIA LIMITED (AU) 1980-02-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184816-A1 Method for Reducing the Phytotoxicity of Azoles on Dicotyledonous Plants by Adding Additives AS3MT, STS, IPMK CA2 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.